Department of Pharmaceuticals of Ministry of Chemicals and Fertilizers announces Revamped Pharmaceuticals Technology Upgradation Assistance Scheme (RPTUAS)

SUN MON TUE WED THU FRI SAT

1 2 3 No article 4 5 6 7 8 9 10 No article 11 12 13 14 15 16 17 No article 18 19 20 21 22 23 24 No article 25 No article 26 No article 27 28 29 30 31 No article

Watch News Today

Posted 12 Mar 2024

Updated 27 Mar 2024

2 min read

Key highlights
- Background: Erstwhile PTUAS is a component of Strengthening of Pharmaceutical Industry (SPI) Scheme.
  - SPI Scheme aims to strengthen the existing infrastructure facilities to make India a global leader in the Pharma Sector.
- Aim:
  - To support the pharmaceutical industry's up-gradation to the Revised Schedule-M & WHO-GMP standards.
    - Schedule-M of the Drugs and Cosmetics Rule, 1945 provides good manufacturing practices (GMP) for pharmaceutical products.
  - Enhancing the quality and safety of pharmaceutical products manufactured in India.
- Broadened Eligibility Criteria: Any pharmaceutical manufacturing unit that requires technology and quality upgradation and fulfils turnover criteria (refer to infographics).
  - Preference remains for MSMEs.
    - Earlier the scheme covered only MSME pharmaceuticals.
- Broadened eligible activities: Activities eligible for incentive include, water and steam utilities, testing laboratories, stability chambers waste management etc.
- Flexible Financing Options: Emphasizes on a reimbursement basis subsidy over a traditional credit-linked approach.
- Allows integration with state government scheme: This provision will enable units to benefit from additional top-up assistance.
- Enhanced Verification: Verification through a Project Management Agency for ensuring transparency, accountability and the efficient allocation of resources.